POTASSIUM CHLORIDE
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- POTASSIUM CHLORIDE
- Generic name
- POTASSIUM CHLORIDE
- Manufacturer
- QUAGEN PHARMACEUTICALS LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 8fac192f-48ab-4def-9c3a-f1cd50b3e2b7
- SPL ID
- 3eb39560-d293-4af3-84b5-d2090b6b406c
- Version
- 3
- Effective date
- 2026-09-29
- Source export date
- 2026-11-13
- Source partition
- 3
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-13/2df682709a18af7b632162dce4573ac151d74d432118e70b8675083d83b89813/drug-label-0003-of-0014.json.zip
- Source manifest SHA-256
- 8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
- Import run
- 20261116T150851Z
- Imported at
- 2026-11-16 15:47:21
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 215716 | derived:openfda.application_number |
| application number | ANDA215716 | openfda.application_number | |
| brand name | POTASSIUM CHLORIDE | openfda.brand_name | |
| generic name | POTASSIUM CHLORIDE | openfda.generic_name | |
| manufacturer name | QUAGEN PHARMACEUTICALS LLC | openfda.manufacturer_name | |
| ndc | package | 70752-151-12 | openfda.package_ndc |
| ndc | package | 70752-150-12 | openfda.package_ndc |
| ndc | product | 70752-150 | openfda.product_ndc |
| ndc | product | 70752-151 | openfda.product_ndc |
| ndc11 | package | 70752015012 | derived:openfda.package_ndc |
| ndc11 | package | 70752015112 | derived:openfda.package_ndc |
| rxcui | 314182 | openfda.rxcui | |
| rxcui | 312515 | openfda.rxcui | |
| spl id | 3eb39560-d293-4af3-84b5-d2090b6b406c | id | |
| spl set id | 8fac192f-48ab-4def-9c3a-f1cd50b3e2b7 | set_id | |
| unii | 660YQ98I10 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
5 WARNINGS AND PRECAUTIONS Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation if administered undiluted. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .
warnings and cautions
5.1 Gastrointestinal Irritation May cause gastrointestinal irritation if administered undiluted. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Quagen Pharmaceuticals LLC at 1-888-344-9603 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.